Always use our prescription products under medical supervision

BRAND NAME

GENERIC NAME

STRENGTH

Adacel®

Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine Adsorbed

One dose of 0.5ml

Avaxim® 80U/160U

Inactivated Hepatitis A vaccine, Adsorbed I.P

One dose of 0.5ml

FluQuadri®

Quadrivalent Inactivated Influenza Vaccine (Split Virion) I.P

One dose of 0.5ml

Hexaxim®

Diphtheria, Tetanus, Pertussis (acellular, component), Hepatitis B (rDNA), Poliomyelitis (inactivated) and Haemophilus influenzae type b conjugate vaccine (adsorbed)

One dose of 0.5ml

Imovax® Polio

Poliomyelitis Vaccine (Inactivated) I.P.

One dose of 0.5ml

Menactra®

Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine

One dose of 0.5ml

Pentaxim®

Adsorbed Diphtheria, Tetanus, Pertussis (Acellular Component), Inactivated Poliomylitis Vaccine and Haemophilus Type B Conjugate Vaccine I.P.

One dose of 0.5ml

Shanchol™

Cholera Vaccine (Inactivated, Oral) I.P.

1.5ml

ShanIPV™

Poliomyelitis vaccine (Inactivated) I.P.

2.5ml ,5ml

Stamaril®

Yellow Fever Vaccine (Live)

One dose of 0.5ml

Vaxigrip®

Inactivated Influenza vaccine, split virion I.P.

One dose of 0.5ml

Tetraxim®

Adsorbed Diphtheria, tetanus, pertussis (acellular component) and Inactivated Poliomyelitis Vaccine I.P

One dose of 0.5ml

Contact us

For seeking medical information, reporting adverse events and product complaints:  1800 22 2295 (toll-free)

For other queries:  022-28032000


For medical information:  medinfo.india@sanofi.com ,  customercare.chc@sanofi.com (Consumer healthcare products)

For reporting adverse events:  PV.india@sanofi.com

For product complaints:  ptcindia@sanofi.com

For other queries :  Write here


All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.

You can email or call us between 9 AM and 5 PM on any working day (we are closed on Saturday, Sunday and public holidays). Please select IVRS option 3 for reporting adverse events.